PATENT CLAIM ANALYSIS

Application Number: 15881493
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "139100"]

Abstract:
The present disclosure provides binding proteins, such as antibodies, that bind glucagon receptors, including a human glucagon receptor, and methods of their use.

Claim (Index 84):
The method of  claim 83 , wherein the at least one additional therapeutic agent is a diabetes or hyperglycemia drug.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13113996', '11903481', '14268933', '15228254', '13625417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7315379023689094
- 35 USC 102 Novelty (BERT): 0.5431885981113359
- Combined Prediction Score: 0.712702971943152
- Mean Citation Score: 362.08624
- Max Citation Score: 379.02307
- Similarity Product: 224.5266979892993

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test